Wockhardt

34
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
1,360.65
29.3 (2.2%)
BSENSE

Dec 05

BSE+NSE Vol: 51.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Wockhardt Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-16.00
-420.00
-624.00
-411.00
915.00
-196.00
Adjustment
455.00
677.00
635.00
554.00
-942.00
483.00
Changes In working Capital
-492.00
-8.00
153.00
367.00
-143.00
379.00
Cash Flow after changes in Working Capital
-53.00
249.00
164.00
510.00
-170.00
666.00
Cash Flow from Operating Activities
-22.00
219.00
153.00
413.00
-287.00
648.00
Cash Flow from Investing Activities
-780.00
-138.00
-118.00
-204.00
1,471.00
-147.00
Cash Flow from Financing Activities
409.00
334.00
-315.00
-71.00
-1,170.00
-679.00
Net Cash Inflow / Outflow
-393.00
415.00
-280.00
138.00
12.00
-178.00
Opening Cash & Cash Equivalents
505.00
90.00
370.00
232.00
219.00
397.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
112.00
505.00
90.00
370.00
232.00
219.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wockhardt
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-16
341.71
-357.00
-104.68%
Adjustment
455
1372.66
-917.00
-66.85%
Changes In working Capital
-492
-487.71
-5.00
-0.88%
Cash Flow after changes in Working Capital
-53
1226.66
-1,279.00
-104.32%
Cash Flow from Operating Activities
-22
892.3
-914.00
-102.47%
Cash Flow from Investing Activities
-780
-488.34
-292.00
-59.72%
Cash Flow from Financing Activities
409
-440.83
849.00
192.78%
Net Cash Inflow / Outflow
-393
-36.87
-357.00
-965.91%
Opening Cash & Cash Equivalents
505
219.19
286.00
130.39%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
112
182.32
-70.00
-38.57%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -110.05% vs 43.14% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-22.00
219.00
-110.05%